ELRAGLUSIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H13FN2O5
Molecular Weight	404.3474
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ELRAGLUSIB

Structure Search

SMILES

CN1C=C(C2=C1C=C3OCOC3=C2)C4=C(C(=O)NC4=O)C5=COC6=C5C=C(F)C=C6

InChI

InChIKey=FARXPFGGGGLENU-UHFFFAOYSA-N

InChI=1S/C22H13FN2O5/c1-25-7-13(11-5-17-18(6-15(11)25)30-9-29-17)19-20(22(27)24-21(19)26)14-8-28-16-3-2-10(23)4-12(14)16/h2-8H,9H2,1H3,(H,24,26,27)

HIDE SMILES / InChI

Molecular Formula	C22H13FN2O5
Molecular Weight	404.3474
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 10:49:43 GMT 2025` Edited by `admin` on `Wed Apr 02 10:49:43 GMT 2025`
Record UNII	ND1SOF0DLU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ELRAGLUSIB

Official Name

English

9-ING-41

Preferred Name

English

Elraglusib [WHO-DD]

Common Name

English

3-(5-FLUORO-1-BENZOFURAN-3-YL)-4-(5-METHYL-5H- (1,3)DIOXOLO(4,5-F)INDOL-7-YL)-1H-PYRROLE-2,5-DIONE

Systematic Name

English

elraglusib [INN]

Common Name

English

3-(5-FLUORO-BENZOFURAN-3-YL)-4-(5-METHYL-5H-(1,3)DIOXOLO(4,5-F)INDOL-7-YL)-PYRROLE-2,5-DIONE

Systematic Name

English

1H-PYRROLE-2,5-DIONE, 3-(5-FLUORO-3-BENZOFURANYL)-4-(5-METHYL-5H-1,3-DIOXOLO(4,5-F)INDOL-7-YL)-

Systematic Name

English

ELRAGLUSIB [USAN]

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

513815

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

FDA ORPHAN DRUG

598217

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

Code System Code Type Description

SMS_ID

300000026357

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

FDA UNII

ND1SOF0DLU

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

CAS

1034895-42-5

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

USAN

KL-03

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

PUBCHEM

44582816

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

INN

11553

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

INN

NCI_THESAURUS

C156792

Created by admin on Wed Apr 02 10:49:43 GMT 2025 , Edited by admin on Wed Apr 02 10:49:43 GMT 2025

PRIMARY

Related Record Type Details


					JJ6Y4XPO7R

GLYCOGEN SYNTHASE KINASE-3 BETA

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					ND1SOF0DLU

ACTIVE MOIETY

Amount: